# LAMIVUDINE, ZIDOVUDINE TABS 150MG/300MG CO-PACKAGED WITH NEVIRAPINE TABS 200MG
> **NDA022356** · New Drug Application · Sponsor: HETERO DRUGS LTD · Approved 2009-05-07
## Drug
- **FDA Application Number:** NDA022356
- **Application type:** New Drug Application
- **Brand name:** LAMIVUDINE, ZIDOVUDINE TABS 150MG/300MG CO-PACKAGED WITH NEVIRAPINE TABS 200MG
- **Generic name:** Lamivudine
- **Active ingredients:** LAMIVUDINE; ZIDOVUDINE; NEVIRAPINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** HETERO DRUGS LTD
- **First approval:** 2009-05-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022356)
---
*AI Analytics · CC0 1.0*